Genetic Markers Indicate that 1,25-dihydroxyvitamin D Treatment may not Protect Against Hepatocellular Carcinoma

ÖNER Ç., ÇOLAK E.

EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY, cilt.5, sa.2, ss.117-122, 2021 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 5 Sayı: 2
  • Basım Tarihi: 2021
  • Doi Numarası: 10.14744/ejmo.2021.65874
  • Dergi Adı: EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.117-122
  • Anahtar Kelimeler: 1.25-Dihydroxyvitamin D, hepatocellular carcinoma, motility, PIWI interacting RNA, proliferation, VITAMIN-D, IN-VITRO, CELL-CYCLE, CANCER, INHIBITION, PATHWAY, GROWTH, TUMORIGENESIS, ANGIOGENESIS, CONTRIBUTES
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

Objectives: The impact of 1,25-dihydroxyvitamin D on hepatocellular carcinoma (HCC) cells is a complicated area. In this study, we aimed to clarify the effect of 1,25-dihydroxyvitamin D on HCC cells according to genetic markers.